Abstract | BACKGROUND: In in vitro experiments, the localized lipophilic cation, MKT-077, demonstrated time- and concentration-dependent antitumor activity. In the present experiment, the in vivo antitumor activity of MKT-077 was evaluated using human tumor xenografts serially transplanted into nude mice. MATERIALS AND METHODS: The antitumor efficacy of MKT-077 against five xenografts inoculated subcutaneously into nude mice was studied. Treatment with MKT-077 was initiated when the tumors started exponential growth. The antitumor activity of MKT-077 was assessed by a) the lowest value of the relative mean tumor weight of the treated:control tumors (T/CRW), where relative weight (RW) represented the change from baseline weight; and by b) the unadjusted weight of treated tumors at the end of the experiment. RESULTS: When MKT-077 was administered continuously using the Osmotic Micropump, antitumor activity was positively correlated with exposure time and drug concentration from 7.5 to 40 mg/kg/day. The maximum tolerated dose was 20 mg/kg/day for 7 days. Co-4 (human colon cancer), St-4 (human gastric cancer), and CRL1420 (human pancreatic cancer) were evaluated as sensitive to MKT-077 in tested 5 strains. CONCLUSION: The antitumor activity of MKT-077 was confirmed using human tumor xenografts in nude mice.
|
Authors | Y Chiba, T Kubota, M Watanabe, S W Matsuzaki, Y Otani, T Teramoto, Y Matsumoto, K Koya, M Kitajima |
Journal | Anticancer research
(Anticancer Res)
1998 Mar-Apr
Vol. 18
Issue 2A
Pg. 1047-52
ISSN: 0250-7005 [Print] Greece |
PMID | 9615763
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Pyridines
- Thiazoles
- MKT 077
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use)
- Humans
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Neoplasms, Experimental
(drug therapy)
- Pyridines
(therapeutic use)
- Thiazoles
(therapeutic use)
- Transplantation, Heterologous
|